Women in Biotech Networking Evening
Join us to celebrate International Women's Day at the first Women in Biotech Networking Evening of 2018. Women from across the sector are invited to enjoy an evening of networking, nibbles and thought provoking presentations from our guest speakers. Professor Joanne Hackett and Dr Jelena Aleksic will explore developments and opportunities in the UK’s genomics industry, focusing of the challenges of data protection and implications for the NHS. Kindly hosted by Instinctif Partners.
We are delighted to have Sue Charles, Managing Partner, Instinctif Partners joining us to chair the evening.
Meet our speakers
Dr Jelena Aleksic
Dr Jelena Aleksic is a Geneticist turned Entrepreneur, working to make clinical genetic testing more accessible.
She completed her PhD at Cambridge University in Genomics and Computational Biology, followed by a postdoc position researching the Epigenetics of a rare genetic disorder, Dubowitz Syndrome.
Having learned about the challenges in diagnosing rare diseases, she co-founded GeneAdviser, an online marketplace for clinical genetic tests, to make it easier for doctors to find and order tests for their patients.
She is also a director of TReND in Africa, a charity supporting scientific research in Africa.
Sue leads the global Life Sciences practice of Instinctif Partners, a leading business communications consultancy.
Having been actively involved with the biotech sector for some three decades, Sue is passionate about helping the UK’s strengths in bioscience innovation translate into commercial and investor success. Her global experience spans advising early stage private to large multinational companies, seeing clients through periods of celebration and challenge, and supporting successful financings both privately and on public markets. She has also provided communications counsel to academic and not-for-profit organisations as well as numerous venture funds. She has contributed to initiatives to encourage the development of talent including as a supporter of BiotechYES and as founder of the ‘Career Alternatives for Scientists’ initiative.
A current member of the BIA Board, Sue is an entrepreneur and business leader who has founded and sold three communications consultancies, an experienced CEO of a biotech spin-out and holder of non-executive positions. Sue was named as one of most inspirational women working in Life Sciences in in 2016 and again in 2017.
Sue has a first class degree in Biochemistry from Oxford and an MBA from Cranfield Business School.
Professor Joanne Hackett
Joanne is the Chief Commercial Officer at Genomics England (GeL). She has been actively involved in clinical research for over 20 years in North America, Europe and the UK. An accomplished entrepreneur, scientist and strategist, she has experience in the execution and management of complex business transactions, as well as broad business development experience in negotiation, execution and management of hundreds of transactions with pharma, biotech, academia and non-profit organisations.
Her expertise in creating connections between industry, academia and the NHS will help inform solutions GeL are currently tackling and support the growth of the UK genomic medicine industry.
Genomics England is a company owned by the Department of Health and was set up to deliver the 100,000 Genomes Project. This flagship project will sequence 100,000 whole genomes from NHS patients and their families. The project is focusing on patients with rare diseases, and their families, as well as patients with common cancers.
17:45 - 18:30 Arrival, registration, networking
18:30 - 19:30 Talks, discussion, Q&A
19:30 - 20:30 Further networking, drinks